Although sufficient for long-term, feeder-dependent growth in vitro, transduction with BCL2 and BCL6, with or without the addition of a dominant negative TP53 (P53dd)30, was insufficient for tumor formation in vivo. This evidence concerns the gene BCL6 and neoplasm.